These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine. Sharun K; Jambagi K; Arya M; Aakanksha ; Chaithra SN; Patel PK; Dixit SK; Dhama K Arch Razi Inst; 2021 Nov; 76(5):1175-1182. PubMed ID: 35355772 [TBL] [Abstract][Full Text] [Related]
4. Expression of substance P and its neurokinin-1 receptor on thymocytes: functional relevance in the regulation of thymocyte apoptosis and proliferation. Santoni G; Amantini C; Lucciarini R; Pompei P; Perfumi M; Nabissi M; Morrone S; Piccoli M Neuroimmunomodulation; 2002-2003; 10(4):232-46. PubMed ID: 12584411 [TBL] [Abstract][Full Text] [Related]
5. Neonatal capsaicin treatment affects rat thymocyte proliferation and cell death by modulating substance P and neurokinin-1 receptor expression. Santoni G; Amantini C; Lucciarini R; Perfumi M; Pompei P; Piccoli M Neuroimmunomodulation; 2004; 11(3):160-72. PubMed ID: 15067207 [TBL] [Abstract][Full Text] [Related]
6. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor. González-Ortega A; Sánchez-Vaderrábanos E; Ramiro-Fuentes S; Salinas-Martín MV; Carranza A; Coveñas R; Muñoz M Peptides; 2014 May; 55():1-12. PubMed ID: 24548567 [TBL] [Abstract][Full Text] [Related]
7. Elevated SP/NK-1R in esophageal carcinoma promotes esophageal carcinoma cell proliferation and migration. Dong J; Feng F; Xu G; Zhang H; Hong L; Yang J Gene; 2015 Apr; 560(2):205-10. PubMed ID: 25659767 [TBL] [Abstract][Full Text] [Related]
8. Neurokinin-1 receptor antagonism improves postoperative neurocognitive disorder in mice. Li Z; Luo T; Ning X; Xiong C; Wu A Neurosci Lett; 2018 Nov; 687():189-195. PubMed ID: 30273701 [TBL] [Abstract][Full Text] [Related]
9. The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer. Muñoz M; González-Ortega A; Salinas-Martín MV; Carranza A; Garcia-Recio S; Almendro V; Coveñas R Int J Oncol; 2014 Oct; 45(4):1658-72. PubMed ID: 25175857 [TBL] [Abstract][Full Text] [Related]
10. Aprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis. Martinez AN; Burmeister AR; Ramesh G; Doyle-Meyers L; Marriott I; Philipp MT J Neuroinflammation; 2017 Feb; 14(1):37. PubMed ID: 28202084 [TBL] [Abstract][Full Text] [Related]
11. A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer. Shi Y; Wang X; Meng Y; Ma J; Zhang Q; Shao G; Wang L; Cheng X; Hong X; Wang Y; Yan Z; Cao Y; Kang J; Fu C Adv Sci (Weinh); 2021 Nov; 8(21):e2101936. PubMed ID: 34605226 [TBL] [Abstract][Full Text] [Related]
12. SP/NK-1R promotes gallbladder cancer cell proliferation and migration. Deng XT; Tang SM; Wu PY; Li QP; Ge XX; Xu BM; Wang HS; Miao L J Cell Mol Med; 2019 Dec; 23(12):7961-7973. PubMed ID: 30903649 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the anti-inflammatory and analgesic properties of maropitant: A systematic review and meta-analysis. Kinobe RT; Miyake Y Vet J; 2020; 259-260():105471. PubMed ID: 32553233 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage. Scholzen TE; Steinhoff M; Sindrilaru A; Schwarz A; Bunnett NW; Luger TA; Armstrong CA; Ansel JC FASEB J; 2004 Jun; 18(9):1007-9. PubMed ID: 15084523 [TBL] [Abstract][Full Text] [Related]
15. Chronic non-peptide neurokinin receptor antagonist treatment alters striatal tachykinin peptide and receptor gene expression in the rat. McCarson KE; Krause JE; McLean S Neurosci Lett; 1998 Jul; 251(2):113-6. PubMed ID: 9718987 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes. Guo CJ; Douglas SD; Gao Z; Wolf BA; Grinspan J; Lai JP; Riedel E; Ho WZ Glia; 2004 Nov; 48(3):259-66. PubMed ID: 15390113 [TBL] [Abstract][Full Text] [Related]
17. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605 [TBL] [Abstract][Full Text] [Related]
18. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists. Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680 [TBL] [Abstract][Full Text] [Related]
20. The anti-inflammatory action of maropitant in a mouse model of acute pancreatitis. Tsukamoto A; Ohgoda M; Haruki N; Hori M; Inomata T J Vet Med Sci; 2018 Mar; 80(3):492-498. PubMed ID: 29343664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]